FDA Inspection 1324334 — Biomat USA Inc

Biomat USA Inc — FEI 3023864731

The FDA completed an inspection of Biomat USA Inc on Jun 5, 2026 in Cape Girardeau, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jun 5, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Cape Girardeau, MO (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.